Pioglitazone for type 2 diabetes mellitus
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Pioglitazone for Type 2 Diabetes Mellitus." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/436737/all/Anti_IgE_therapy_for_allergic_bronchopulmonary_aspergillosis_in_people_with_cystic_fibrosis:_Cochrane_systematic_review. Accessed 29 March 2024.
Pioglitazone for type 2 diabetes mellitus. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/436737/all/Anti_IgE_therapy_for_allergic_bronchopulmonary_aspergillosis_in_people_with_cystic_fibrosis:_Cochrane_systematic_review. Accessed March 29, 2024.
Pioglitazone for type 2 diabetes mellitus. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/436737/all/Anti_IgE_therapy_for_allergic_bronchopulmonary_aspergillosis_in_people_with_cystic_fibrosis:_Cochrane_systematic_review
Pioglitazone for Type 2 Diabetes Mellitus [Internet]. In: Cochrane Abstracts. [cited 2024 March 29]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/436737/all/Anti_IgE_therapy_for_allergic_bronchopulmonary_aspergillosis_in_people_with_cystic_fibrosis:_Cochrane_systematic_review.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Pioglitazone for type 2 diabetes mellitus
ID - 436737
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/436737/all/Anti_IgE_therapy_for_allergic_bronchopulmonary_aspergillosis_in_people_with_cystic_fibrosis:_Cochrane_systematic_review
DB - Evidence Central
DP - Unbound Medicine
ER -